Lower glycolysis involves a series of reversible reactions, which interconvert intermediates that also feed anabolic pathways.
AMPK activation can both suppress anabolic pathways that consume energy and stimulate catabolic pathways that produce ATP.
AMPK has been shown to inhibit anabolic pathways such as protein translation and fatty acid and cholesterol synthesis, thus limiting ATP utilization during energetic stress.
Decreased expression of hepatic Cpt1a could reduce fatty acid catabolism but promote anabolic pathways thus resulting in lipid accumulation and hypertriglyceridemia24.
Daytime communities encoded greater abundances of genes for anabolic pathways, such as fatty acids, cofactors, DNA and RNA metabolism, cell wall biosynthesis, molecular regulation and cell cycle pathways (Fig. 3a).
Anabolic pathways, on the other hand, are sequences of enzyme-catalyzed reactions in which the component building blocks of large molecules, or macromolecules (e.g., proteins, carbohydrates, and fats), are constructed from the same intermediates.
But, although catabolic and anabolic pathways are closely linked, and although the overall effect of one type of route is obviously the opposite of the other, they have few steps in common.
AMPK is a cellular energy sensor whose activation can both block anabolic pathways such as protein synthesis and activate catabolic reactions such as fatty acid oxidation to maintain cellular bioenergetics.
Such regulatory circuits ensure that anabolic pathways remain repressed unless final products are in short supply and that catabolic enzymes are not produced in absence of their substrates.
These tracers were designed to probe the central energy producing and anabolic pathways (glycolysis, pentose phosphate pathway, Krebs Cycle, glutaminolysis, nucleotide synthesis and lipid turnover).
For this purpose a model was created, considering all CO2 forming and consuming reactions in the central catabolic and anabolic pathways.
